Sloan Leslie 4
4 · Aeglea BioTherapeutics, Inc. · Filed Feb 19, 2020
Insider Transaction Report
Form 4
Sloan Leslie
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2020-02-14+100,000→ 100,000 totalExercise: $8.15Exp: 2030-02-13→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 14, 2020, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.